Cargando…
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
PURPOSE: To elucidate the role of biological and clinical impact of aberrant promoter hypermethylation (PH) in ovarian cancer (OC). EXPERIMENTAL DESIGN: PH of PGP9.5, HIC1, AIM1, APC, PAK3, MGMT, KIF1A, CCNA1, ESR1, SSBP2, GSTP1, FKBP4 and VGF were assessed by quantitative methylation specific PCR (...
Autores principales: | Brait, Mariana, Maldonado, Leonel, Noordhuis, Maartje, Begum, Shahnaz, Loyo, Myriam, Poeta, Maria Luana, Barbosa, Alvaro, Fazio, Vito M., Angioli, Roberto, Rabitti, Carla, Marchionni, Luigi, de Graeff, Pauline, J. van der Zee, Ate G., Wisman, G. Bea A., Sidransky, David, Hoque, Mohammad O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785492/ https://www.ncbi.nlm.nih.gov/pubmed/24086249 http://dx.doi.org/10.1371/journal.pone.0070878 |
Ejemplares similares
-
Correction: Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
por: Brait, Mariana, et al.
Publicado: (2013) -
Correction: Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
por: Brait, Mariana, et al.
Publicado: (2013) -
High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas
por: Inokawa, Yoshikuni, et al.
Publicado: (2022) -
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
por: Hayashi, Masamichi, et al.
Publicado: (2014) -
PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors
por: Tomita, Tatsuo
Publicado: (2013)